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Introduction
Each of us unequivocally owns a unique object, our own body. 
It is ‘unique’ because it is a multisensory object.1 This univo-
cal multisensoriality is provided by a complex and integrated 
network of cortical areas coding for different types of stimuli, 
the so-called ‘body matrix’.2 The brain houses multiple repre-
sentations of the body3 and this set of representational systems 
makes us capable of experiencing what happens to us, viewed 
both from the inside and the outside. In order to better study 
and explain this duality, Longo et al.4 suggest differentiating 
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the modality by which we feel our body from the inside, as an 
object of direct perception (somatoperception), from the other 
modality by which we can cognitively reflect the body from 
the outside (somatorepresentation). With the former, we can 
perceive our body and objects contacting it, while with the 
latter we can consider our body as a physical and biological 
object like another in the external world, with which we estab-
lish a relationship.1
Moreover, Longo et al.4 highlight another important dif-
ference between these two high-order processes (somatoper-
ception and somatorepresentation), and the basic mechanisms 
producing the sensations of touch, proprioception, cold, 
warm, nociception, and vision (called somatosensation). 
These three different mechanisms are integrated and linked,2 
but are independent of each other. The integrity of the periph-
eral receptors deputed to somatosensation, for example, is 
neither sufficient nor necessary to produce somatoperception 
or somatorepresentation. The most striking demonstration of 
this phenomenon is represented by the illusory perception of 
owning a limb (somatoperception) when the person knows 
that it has been amputated (somatorepresentation), and all 
the sensitive receptors are physically missing from that body 
part (somatosensation). The fact that this perceptual sensa-
tion is referred to as vivid and has detailed sensorial charac-
teristics indicates that the peripheral information has been 
stored somewhere centrally in the brain: sensations from the 
‘old’ limb are maintained in a body structure model of refer-
ence and continue to exist even in the absence of the limb 
itself.3 It follows that there may be a dissociation between 
these different components of mental representation of the 
body and the primary sensory process because each one has 
different underlying functional and neuro-anatomical bases 
(see Longo et al.4 for a detailed dissertation and other 
examples).
However, we have a less accurate knowledge of 
somatoperception and somatorepresentation because the 
mechanisms underlying somatosensation have been the pri-
mary focus of studies conducted in experimental Psychology 
and Neurophysiology.4
Pain itself can induce alterations in body/space percep-
tion.5,6 In turn, modifications in the way by which we per-
ceive our bodies (e.g. through visual manipulations)7–9 or the 
space with which our bodies interact10,11 may have implica-
tions in pain perception. These results highlight how the 
complex experiences of pain perception and body perception 
itself may depend on multisensorial representations stored in 
our brains, and how they may be potentially linked.2,12,13 
Pain represents the conscious perception that the body is 
threatened; it follows that it is fundamental to understand 
how a body that needs protection is perceived, because these 
mechanisms may be related to the emergence of pain itself.14 
It is noteworthy from a clinical and therapeutic perspective 
that this kind of ‘bizarre’ body perception disturbance may 
not be referred by patients to health care providers, if it is not 
directly questioned15,16 for fear of not being believed17 or of 
being considered mentally disturbed.18 Thus, overall, how 
we mentally represent our bodies may influence our quality 
of life, social interactions, and mental health.17,19
Phenomena of disturbed somatoperception and soma-
torepresentation have been documented in a variety of clini-
cal neuropathic pain conditions affecting the musculoskeletal 
system, and particularly in Complex Regional Pain Syndrome 
(CRPS)15,17,20,21 and phantom limb pain,22,23 but remain 
undiscovered for musculoskeletal disorders and rheumatic 
diseases (MDRDs). Moreover, while compelling prelimi-
nary evidence about interactions between body representa-
tion and space perception have been published in 
CRPS,11,20,24–27 this interaction remains to be clarified in 
MDRDs. Considering the correlation between body percep-
tion dysfunction with pain intensity17,26,28 and duration17,29 
highlighted in CRPS, it seems to be clinically important to 
clarify if this link exists in MDRDs. Thus, in order to have a 
complete overview of this research area, a literature search 
must be conducted to guide further research and clinical 
practice. Figure 1 summarizes the theoretical bases and the 
aims of this review.
Moreover, different terminologies have been used in sci-
entific literature to describe body perception and mental rep-
resentations, and the relative meanings assigned within this 
terminology are sometimes ambiguous or contradictory,30 
making it difficult to uniformly cover this research area. 
Although the issue of the terminology used is still under 
debate,31 for the purpose of the present review, we arbitrarily 
refer to somatosensation and the other higher-order pro-
cesses, namely, somatoperception and somatorepresenta-
tion, as defined by Longo et al.4
Aim
The aim of this review is to map and examine the magnitude 
and nature of available published research about distur-
bances of explicit and implicit19 mechanisms of body per-
ception, body representation, and perception of surrounding 
space in MDRDs. The present protocol represents a detailed, 
step-by-step description of how we intend to conduct the 
scoping review in order to limit the occurrence of reporting 
bias. Any deviations from the protocol that may occur will be 
addressed and explained in the final scoping review report.
Materials and methods
The scoping design approach was selected in order to 
systematically32,33 map and synthesize the research trends and 
findings on body perception and body representation that 
seem to be applicable in the clinical context of MDRDs. The 
scoping study represents the most appropriate method of over-
viewing the literature about an emergent research area which 
is still fragmented, complex, wide, poorly understood, or 
not previously deeply investigated.33,34 Our methodology 
is inspired by recently published scoping studies and 
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protocols.34–36 Our research team will use the six-step frame-
work for scoping review developed by Arksey and O’Malley37 
and supplemented by Peters et al.,38 as a guide. Moreover, it 
will follow the recommendations of Daudt et al.39 to enhance 
the six framework stages of Arksey and O’Malley. The six 
steps (five mandatory and one optional) are detailed below:
Step 1. Identifying research questions
•• Are there any documented modifications of the implicit 
and explicit cognitive and perceptual representations of 
one’s own body in MDRDs affected patients?
•• Do these phenomena show different features between 
MDRDs patients and those with other disorders, or are 
there different features between MDRD sub-groups?
•• What are the methodologies used to explore these phe-
nomena? Are they easily applicable in clinical practice?
•• When related to the body, the terms perception, repre-
sentation, and their synonyms can be ambiguous and 
differently interpreted depending on the specific ref-
erence areas and disciplines. We aim to investigate 
what terminology is used in different publications, by 
whom and for what purpose, including inter-article 
concordance.
Step 2. Identify relevant studies
We will follow the acronym PCC (Population, Concept, 
and Context) proposed by The Joanna Briggs Institute40 to 
describe elements of the inclusion criteria.
Population
The studies included will report data about adult individuals 
(>16 years old) of both sexes, affected by MDRDs, for 
example, low back pain, neck pain, osteoarthritis, rheuma-
toid arthritis, and fibromyalgia.
Concept
The main concept of this review will be the potential altera-
tions involved in how patients perceive their body and/or sur-
rounding space. Another core concept of this review refers to 
the characteristics (entity, typology, theoretical bases, and 
practical implications) of the potential disturbances involved.
Figure 1. Summary of theoretical bases and aims of the scoping review.
4 SAGE Open Medicine
Context
Literature specifically concerning MDRDs will be reviewed. 
Both experimental and clinical settings will be considered. 
However, we will focus mainly on the studies which relied 
on measures, methodologies, and/or tests that are adminis-
trable in clinical practice.
Types of studies
Quantitative and qualitative studies will be included in this 
review in order to better overview the current state of the art 
about the topic. Details on criteria for including and exclud-
ing studies are shown in Table 1. Studies that are included 
must be published on humans in English or, if not in English, 
then containing an English abstract, with additional informa-
tion of an earlier or ongoing trial study report. Data from 
these last sources will be extracted based on the information 
available in the abstract. However, we will keep a record of 
studies published in other languages in order to provide a 
general overview of the amount of international literature 
published.
Measure of outcomes for body perception and 
representation
The details are summarized in Table 1.
Search strategy and information sources
The multidisciplinary team composed of physiotherapists, 
neurologists, and psychologists will define search strategy. 
As recommended by Valaitis et al.,41 we will follow a three-
step search strategy. First, a preliminary search will be pilot 
tested in order to pre-select key words from abstracts and 
titles of papers considered relevant to the topic. This step 
will only involve two online databases, Medline (PubMed) 
and the Cochrane Library. Moreover, we will use PubReMiner 
(a free version data mining tool: http://hgserver2.amc.nl/cgi-
bin/miner/miner2.cgi) in order to retrieve additional key 
words and Mesh terms to assemble in the final search query. 
Based on the key words and Mesh terms retrieved, a defini-
tive search strategy will be developed using Medline 
(PubMed interface) (see Supplemental Appendix I). This pri-
mary search strategy will be peer-reviewed independently by 
two of the co-authors using the PRESS 2015 Evidence-
Based Checklist42 and re-adjusted after suggestions. The 
search strategy is detailed in Supplemental Appendix I. 
Search history and the peer review of the search strategy will 
be available upon request. We will use a wide range of search 
terms but also manual filters for Species (Human) in order to 
balance the comprehensiveness and specificity of the search 
strategy with feasibility. No date limitations will be imposed 
for the search strategy.
A secondary search strategy will be performed by adjust-
ing the primary search strategy for all the other databases 
included. Finally, in order to retrieve additional sources, a 
third strategy will be adopted: the four journals with the 
highest impact factor in the field of MDRDs will be elec-
tronically searched, and the reference list of all the articles 
and reviews of interest identified will be scanned. Moreover, 
inherent articles provided by each member of the team after 
searching personal databases will be analysed. If necessary, 
authors of the original studies will be contacted for further 
information or missing data.
Differently from systematic reviews, scoping reviews are 
characterized by an iterative search process rather than a 
fixed and pre-established one. For this reason, our search 
strategy and the inclusion/exclusion criteria may be changed 
and updated during the development of the review, following 
the feedback of the research team, if required.
Data management. All references of identified records will be 
imported and managed with Zotero (https://www.zotero.
org/); this will allow us to remove duplicates. A Google Drive 
folder will be used to share sources between team members.
Electronic databases. The search will be conducted in the fol-
lowing electronic databases: MEDLINE (PubMed), The 
Cochrane Library, The Cochrane Central Register of Controlled 
Trials (CENTRAL), The Campbell Library, the Physiotherapy 
Evidence Database (PEDro), SCOPUS, PsycINFO, Web of Sci-
ence, TRIP Database, and ProQuest Central database. Theses 
and dissertations will be searched on PQDT Open. In addition, 
a search for grey literature will be conducted through corre-
spondence with specialists and experts as well as using web 
search engines (i.e. Google, Google Scholar), limited to the first 
100 citations. A secondary review will be performed by scan-
ning the Grey Matters Checklist (https://www.cadth.ca/
resources/finding-evidence/grey-matters) of the Canadian 
Agency for Drugs and Technology in Health and searching the 
conference abstracts contained therein. The search strategy will 
be modified and adapted, if required, in order to balance the 
thoroughness and relevance of the records with the total volume 
and the feasibility of data management. The International Pro-
spective Register of Systematic Reviews database (PROS-
PERO) has been previously searched in order to check whether 
there are any reviews already registered on this topic.
Step 3. Study selection
The reviewing process will be carried out in two different 
steps: (1) preliminary identification of relevant studies 
based on the title and/or abstract; (2) study selection based 
on the eligibility criteria (see Table 1). For the first step, 
before starting the screening, the researchers will perform a 
pilot test, pre-formal screening for a random 10% of the 
records retrieved on PubMed as a calibration exercise, with 
the goal of improving reliability across reviewers. For the 
second step, pre-formal screening will be performed on a 
random 10% of overall records retrieved on all databases 
included. For both calibration tests, percentage inter-rater 
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agreement will have to be >90% in order to start the formal 
screening:34 if agreement observed is lower, the inclusion 
and exclusion criteria will be clarified and another round of 
pilot testing will be performed. Feedback from this test will 
also be used to refine inclusion/exclusion criteria. Another 
pilot trial charting exercise will be performed prior to data 
abstraction in order to improve the adherence of extracted 
information with research questions and objectives.37–39,41,43 
Study features coming from a convenience sample of five 
of the included articles will be extracted separately by two 
reviewers. A pilot form of the spreadsheet developed a pri-
ori will be used and the inter-rater agreement will be veri-
fied. If necessary, the spreadsheet will be modified, based 
on the research team feedback, until it reaches 90% or more 
inter-reviewer agreement.44
In the first step, records screening will be conducted to 
determine the eligibility of the studies. Each record will be 
considered as included, excluded, or uncertain. At this stage, 
uncertain studies will not be eliminated; these records will be 
analysed in the second stage, undergoing a full-text review 
Table 1. Eligibility criteria for included and excluded studies.
Inclusion criteria Exclusion criteria
Studies investigating alterations of the implicit and explicit body and space perception, 
body representation, and the characteristics of neurocognitive impairments (entity, 
typology, theoretical bases, and practical implications) to these associated.
Language: Full text in Englisha
Setting: Experimental or clinicalb
Participants:
Studies on humans (>16 years old), male and female
Patients affected by musculoskeletal disorders or rheumatic diseases (i.e. low back 
pain, neck pain, osteoarthritis, rheumatoid arthritis, and fibromyalgia), including 




-• Experimental designs (randomized controlled trials, controlled clinical trials, 
proceedings,c conference abstractsc)
-• Observational designs (descriptive studies, surveys, cohort studies, cross-
sectional studies, observer-reported or patient-reported outcome studies, 
case studiesc and case series,c proceedings,c and conference abstractsc)
•• Qualitative designs: phenomenological and grounded theory approaches
Secondary research studies:
-• of quantitative studies: systematic review with or without meta-analysis, 
observational
-• of qualitative studies: meta-summary, meta-synthesis
Outcomes:
•• Quantitative research design:
-• Primary outcomes:
measures, methodologies, and tests used by authors to assess body 
perception, body representation, and perception of surrounding space, the 
association between pain (intensity and duration) and disturbances of body 
perception, body representation, and perception of surrounding space
-• Secondary outcomes:
the association between neuro-anatomical and/or neurophysiological 
correlates and measures of body perception
•• Qualitative research design:
-• Primary o.utcomes:
the frequency and typology of words used by patients in describing 
the alterations of one’s own body perception or representation in 
musculoskeletal disorders and rheumatic diseases. Themes and subthemes 
will be derived by the analysis of patient interviews
Studies investigating body image intended 
as the satisfaction about one’s own bodily 
appearance
Language: Full text and abstract not in Englishe
Participants:
•• Patients affected by:
-• neuropathic pain (e.g. complex 
regional pain syndrome – CRPS, 
phantom limb pain) or myelopathies
-• Eating disorders (e.g. anorexia, 
bulimia)
-• Psychiatric or neurological conditions 
(e.g. personality dissociation, 
somatoform disorders, body identity 
integrity disorders – BIID, dementia, 
Alzheimer and Parkinson diseases, 
multiple sclerosis, stroke, cerebral 
palsy, spinal cord diseases)
-• Congenital, hereditary, or endocrine 
abnormalities and deformities (e.g. 
pectus carinatum, phocomelia, 
acromegaly, gigantism, Marfan 
syndrome, benign joint hypermobility 
syndrome)
-• Neoplastic or post-neoplastic 
conditions (e.g. breast cancer)
Study design:
•• Narrative reviewd
•• Editorials, commentaries or expert 
opinion articles, point of view, letters to 
editors, correspondences or replies to 
letters,e book reviews, or chapters
•• Study protocolf
aOr full text not in English but with the abstract in English, only if containing additional information of an earlier or ongoing trial study report.
bWith a particular focus on studies reporting methodologies or test/measures feasible to translate into clinical practice.
cDescribed with a rigorous methodology.
dA reference list of narrative review about the topic of interest will be manually scanned.
eIncluded in the qualitative analysis only if containing additional information on an earlier or ongoing trial study report.
fExcluded from the analysis but reported in order to provide a general overview of the amount of international literature published.
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best fitting the inclusion and exclusion criteria. The PRISMA 
(Preferred Reporting Items for Systematic Reviews and 
Meta-Analyses) flow chart45 will be used to report the search 
process and the final numbers of articles included in the 
qualitative analysis. An excel spreadsheet will be used to 
report all results from the two searching steps and to assign a 
univocal identification number to each record.
Two reviewers with different backgrounds, for example, a 
neuropsychologist and a physiotherapist, will perform all 
screening steps independently. The multidisciplinary nature 
of our research team, which includes physiotherapists, neu-
rologists, neuropsychologists, and methodologists, along 
with its inter-professionality, that is, members trained in 
clinical practice and academic researchers,46,47 is highly 
appreciable, especially in this area of research, which has 
historically been addressed within psychological disciplines. 
By contrast, in this review, the area of research is discussed 
from the rehabilitation perspective. Discrepancies during the 
screening phase will be resolved via discussion between 
reviewers until a consensus is reached; in case of persistent 
disagreement, a third reviewer will be introduced.
Findings emerging from the review will be organized 
around the research questions previously mentioned. One 
reviewer will extract standard information about the studies’ 
characteristics and background, as well as additional informa-
tion, using a standardized excel spreadsheet (see Supplemental 
Appendix II), which may be modified after the pilot trial 
charting exercise. Another member of the team will check the 
correspondence of data extracted with the research questions 
and goals of the review by doing a full-text reading.
After this calibration exercise procedure, a single reviewer 
will extract data from each study included, which will be 
verified by another member of the team. A third reviewer 
will resolve any disagreement.
Step 4. Charting the data
A summary for numerical results and qualitative analysis 
will be reported and, if possible, data will be graphically 
charted.
Step 5. Collating, summarizing, and reporting the results
Results will be qualitatively and quantitatively synthesized 
in order to determine what has already been discovered in 
this research area and what requires a more in-depth investi-
gation, in line with the research purpose. In agreement with 
the concept of ‘literature map’, results will be presented 
graphically as suggested by Peters et al.38
Methodological quality appraisal
Quality critical appraisal of risk of bias will not be performed 
in line with guidance on scoping review conduct.38 Since stud-
ies in this area tend to be non-homogeneous in terms of their 
methodology and study designs, the present scoping review is 
intended as a broad overview of the evidence pertaining to a 
topic, irrespective of study quality. Moreover, the emerging 
nature of the topic in question renders it difficult to appraise 
the quality of the methodology used in each study. In fact, the 
main goal of this study, unlike that of systematic reviews, is to 
map and synthesize the evidence available about this topic 
rather than provide the best available evidence.38,40
Step 6. Consultation phase (optional)
If considered potentially helpful by the research team, a con-
sultation phase will be introduced with the goal of getting 
additional sources of information and perspectives related to 
the scope of inquiry.37 More in detail, this step may be intro-
duced if a conflicting use of the terminology emerges related 
to the alteration in body perception and representation, and/or 
if the studies included are scarce, come from different settings, 
or are obtained through very different research designs. This 
step can potentially provide insights on the meaning and appli-
cability of findings, highlighting what the literature fails to 
clarify and how research in this area could be improved. 
Researchers involved in this project are experts in the field of 
body perception and representation; their publications on this 
topic attest to their expertise. Moreover, other professionals 
will be involved (such as physiotherapists, neurologists, psy-
chologists, and neurophysiologists) that may share additional 
references, provide new knowledge, or improve the debate 
around the theme of this scoping review through their exper-
tise. Recruitment will take place by personal email invitation. 
Experts will be invited to discuss the strengths and limitations 
of published studies, interpretation of the findings, clinical 
applicability, and proposal to guide future research in this area. 
Ways to standardize the terminology used if discrepancies 
emerge in the findings of the review will also be discussed. 
Email correspondence and face-to-face or Skype meetings 
will be used to discuss how to improve research methodology 
within this topic and what main areas could be further investi-
gated. A semi-structured spreadsheet will be administered in 
order to systematically aggregate the questions raised and the 
suggestions provided.
Discussion
We aim to review scientific literature published on the dys-
functions of implicit and explicit body perception, body repre-
sentation, and perception of surrounding space in patients with 
MDRDs. Our goals are (1) to delimit the state of the art, (2) to 
clarify the currently used terminology, and (3) to define the 
clinical usefulness and feasibility of the diagnostic and thera-
peutic methodologies studied. Through the publication of this 
protocol, we intend to define and outline the step-by-step pro-
cedure to conduct the scoping review in order to limit the 
occurrence of reporting bias. Any deviations from the protocol 
will be reported in the final draft of the scoping review.
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The scoping design approach has been selected for its 
appropriateness in overviewing the literature published on 
an emergent complex and fragmented research area that has 
not been systematically studied before. We adopt the meth-
odological framework currently recognized for conducting 
systematic reviews,33,37–39,47,48 modelling this protocol on 
those previously published by other authors.34,35
Ethics
The present review is not a primary research study and does 
not require formal ethical approval.
Dissemination
In recent years, the publication of review (included scoping 
review) protocols has increased in order to improve the 
transparency process, which is considered important as a 
validity criterion. This research protocol aims to outline the 
methodological steps planned in conducting and reporting 
the review. The results of this overview will be of interest for 
clinicians and researchers involved in the area of body per-
ception, body representation, and perception of surrounding 
space. It may be of particular interest for physiotherapists 
treating MDRDs, aiming to better understand body percep-
tion disturbances and their potential role in developing and/
or perpetuating long-lasting pain.
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